A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
Conditions
- Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Primary Cutaneous Follicle Centre Lymphoma
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Mantle Cell Lymphoma
- Plasma Cell Neoplasm
- B Cell Lymphoma
Interventions
- DRUG: Autologous chimeric antigen receptor T cell transfusing agent targeting CD22
Sponsor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Collaborators